Formalin-inactivated coxiella burnetii phase i vaccine-induced protection depends on b cells to produce protective igm and igg

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2112-2122

  Zhang, Guoquan ^a   Peng, Ying ^a   Schoenlaub, Laura ^a   Elliott, Alexandra ^a   Mitchell, William ^a   Zhang, Yan ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; FORMALDEHYDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; Q FEVER VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL LOAD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; Q FEVER; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COXIELLA BURNETII; FEMALE; FORMALDEHYDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED STRAINS; Q FEVER; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, INACTIVATED; VIRULENCE;

EID: 84877812917     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00297-13     Document Type: Article

References (31)

1. Stoker MG, Fiset P. 1956. Phase variation of the Nine Mile and other strains of Rickettsia burnetii. Can. J. Microbiol. 2:310-321.
2. Ackland JR, Worswick DA, Marmion BP. 1994. Vaccine prophylaxis of Qfever.Afollow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med. J. Aust. 160:704-708.
3. Waag DM, England MJ, Tammariello RF, Byrne WR, Gibbs P, Banfield CM, Pitt ML. 2002. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol. Vaccine 20:2623-2634.
4. Williams JC, Damrow TA, Waag DM, Amano K. 1986. Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice. Infect. Immun. 51:851-858.
5. Lu H, Xing Z, Brunham RC. 2002. GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis. J. Immunol. 169:6324-6331.
6. Ko J, Splitter GA. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78.
7. Abinanti FR, Marmion BP. 1957. Protective or neutralizing antibody in Q fever. Am. J. Hyg. (Lond.) 66:173-195.
8. Brezina R, Kazar J. 1965. Study of the antigenic structure of Coxiella burnetii. IV. Phagocytosis and opsonization in relation to the phases of C. burnetii. Acta Virol. 9:268-274.
9. Kazar J, Skultetyova E, Brezina R. 1975. Phagocytosis of Coxiella burnetii by macrophages. Acta Virol. 19:426-431.
10. Kishimoto RA, Veltri BJ, Canonico PG, Shirey FG, Walker JS. 1976. Electron microscopic study on the interaction between normal guinea pig peritoneal macrophages and Coxiella burnetii. Infect. Immun. 14:1087-1096.
11. Humphres RC, Hinrichs DJ. 1981. Role of antibody in Coxiella burnetii infection. Infect. Immun. 31:641-645.
12. Zhang G, Russell-Lodrigue KE, Andoh M, Zhang Y, Hendrix LR, Samuel JE. 2007. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice. J. Immunol. 179:8372-8380.
13. Shannon JG, Cockrell DC, Takahashi K, Stahl GL, Heinzen RA. 2009. Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor-and complement-independent. BMC Immunol. 10:26. doi:10.1186/1471-2172-10-26.
14. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academies Press, Washington, DC.
15. Ho T, Htwe KK, Yamasaki N, Zhang GQ, Ogawa M, Yamaguchi T, Fukushi H, Hirai K. 1995. Isolation of Coxiella burnetii from dairy cattle and ticks, and some characteristics of the isolates in Japan. Microbiol. Immunol. 39:663-671.
16. Williams JC, Cantrell JL. 1982. Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice. Infect. Immun. 35:1091-1102.
17. Zhang GQ, Samuel JE. 2003. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann. N. Y. Acad. Sci. 990:510-520.
18. Li S, Holers VM, Boackle SA, Blatteis CM. 2002. Modulation of mouse endotoxic fever by complement. Infect. Immun. 70:2519-2525.
19. Shapiro S, Beenhouwer DO, Feldmesser M, Taborda C, Carroll MC, Casadevall A, Scharff MD. 2002. Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect. Immun. 70:2598-2604.
20. Harvill ET, Osorio M, Loving CL, Lee GM, Kelly VK, Merkel TJ. 2008. Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors. Infect. Immun. 76:2177-2182.
21. Zhang X, Goncalves R, Mosser DM. 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter 14:Unit 14.1. doi:10.1002/0471142735.im1401s83.
22. Zhang Y, Zhang G, Hendrix LR, Tesh VL, Samuel JE. 2012. Coxiella burnetii induces apoptosis during early stage infection via a caspaseindependent pathway in human monocytic THP-1 cells. PLoS One 7:e30841. doi:10.1371/journal.pone.0030841.
23. Brennan RE, Samuel JE. 2003. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41:1869-1874.
24. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE. 2007. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect. Immun. 75:3245-3255.
25. + T cells in clearance of primary pulmonary infection with Coxiella burnetii. Infect. Immun. 78:3019-3026.
26. Casadevall A, Pirofski LA. 2004. New concepts in antibody-mediated immunity. Infect. Immun. 72:6191-6196.
27. Casadevall A, Pirofski LA. 2006. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immunol. 91:1-44.
28. Kishimoto RA, Veltri BJ, Shirey FG, Canonico PG, Walker JS. 1977. Fate of Coxiella burnetti in macrophages from immune guinea pigs. Infect. Immun. 15:601-607.
29. Hinrichs DJ, Jerrells TR. 1976. In vitro evaluation of immunity to Coxiella burnetii. J. Immunol. 117:996-1003.
30. Shannon JG, Heinzen RA. 2008. Infection of human monocyte-derived macrophages with Coxiella burnetii. Methods Mol. Biol. 431:189-200.
31. Peacock MG, Fiset P, Ormsbee RA, Wisseman CL. 1979. Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine. Acta Virol. 23:73-81.